Do I need a prescription for Terfenadine 60mg tablets?

Terfenadine 60mg tablets is classified as a Valid as a prescribable product in the UK. However, always consult a pharmacist or doctor before use. (Source: NHS dm+d)

What are the brand names for Terfenadine 60mg tablets?

Terfenadine 60mg tablets is the generic name. It is available under brand names including: Terfenadine 60mg tablets, Terfenadine 60mg tablets, Terfenadine 60mg tablets. (Source: NHS dm+d — Actual Medicinal Products)

Terfenadine 60mg tablets

Tablet

60mg

Oral

In the U.S., Terfenadine was superseded by fexofenadine in the 1990s due to the risk of cardiac arrhythmia caused by QT interval prolongation.

Active ingredients:

Terfenadine

BNF classificationBrowse formulary

Where this medicine sits in the British National Formulary — the UK's standard prescribing reference

BNF 03.04.01

ATC classificationBrowse ATC index

International classification by the WHO, grouping medicines by the organ system they act on

ATC R06AX12

Chemical classBrowse classes

Classification based on the molecule's chemical structure and properties

Check interactions for Terfenadine

No active safety alerts

Official documents, adverse reaction reporting, and safety monitoring

Report a side effect

Submit a Yellow Card report to the MHRA

Official medicine documents

Yellow Card

Report side effects (MHRA)

Drug safety updates

MHRA alerts for Terfenadine

Source: MHRA Products DatabaseOGL 3.0

Updated 3 months ago(16 Jan 2026)

Safety monitoring data

Yellow Card reports

MHRA

The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.

View Drug Analysis Profile

Suspected adverse reactions reported for Terfenadine

Browse all iDAP reports

Interactive Drug Analysis Profiles for all medicines

Report a side effect

Submit a Yellow Card report to the MHRA

Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.

EudraVigilance

EMA

The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.

View EudraVigilance report

Suspected adverse reactions reported for Terfenadine

About EudraVigilance

Learn about EU pharmacovigilance and safety monitoring

EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.

3 branded products available

3 productsShow details

3 products

Possibly available on the UK marketDiscontinuedAvailability per NHS dm+d

MHRA licensed products

View all licensed products for Terfenadine on the MHRA register

Terfenadine 60mg tablets

A A H Pharmaceuticals Ltd

Discontinued

Terfenadine 60mg tablets

Approved Prescription Services Ltd

Discontinued

Terfenadine 60mg tablets

The Boots Company Plc

Discontinued

Source: NHS dm+dOGL 3.0

Updated about 1 month ago(1 Mar 2026)

Daily doseShow details

WHO defined daily dose (DDD)

120 mg

Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.

Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via NHS dm+d BNF mapping files. Contains public sector information licensed under the Open Government Licence v3.0.

Therapeutically similar medicines

10 similarShow details

Fexofenadine 30mg/5ml oral suspension

Oral suspension

30mg/5ml

Same therapeutic group

Bilastine 2.5mg/ml oral solution sugar free

Oral solution

2.5mg

Same therapeutic group

Bilastine 10mg orodispersible tablets sugar free

Tablet

10mg

Same therapeutic group

Loratadine 5mg/5ml oral solution sugar free

Oral solution

5mg/5ml

Same therapeutic group

Rupatadine 1mg/ml oral solution

Oral solution

1mg

Same therapeutic group

Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.

NHS prescribing volume and spending trends

Show details

Loading prescribing data...

Clinical guidelines and formulary information

British National Formulary

Terfenadine

BNF

Drug monograph — bnf.nice.org.uk

Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.

NICE clinical guidance(1)

Gastroparesis in adults: oral erythromycin (ESUOM13)

ESUOM13

Evidence summary

Updated Jun 2013

Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.

Check stock at pharmacies and supply information

Show details

Pharmacy stock checkers

Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.

Boots

Search products

Click & collectNHS

Lloyds

Search products

DeliveryNHS

P2U

Pharmacy2U

Search products

DeliveryNHS

Supply & product information

Official product databases and supply status monitoring

Shortages info

NHS Specialist Pharmacy Service (SPS)

emc product search

Discontinuations & alternatives for Terfenadine

Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.

Codes for healthcare professionals and prescribing systems

Show details

These codes are used by healthcare IT systems and prescribers to identify this medicine.

NHS UK identifiers

SNOMED CT

42196711000001107

dm+d ID

42196711000001107

VTM (Virtual Therapeutic Moiety)

777714006

VMP (Virtual Medicinal Product)

42196711000001107

BNF code

03040100

International identifiers

ATC code — Anatomical Therapeutic Chemical (WHO)

R06AX12

Browse tools

dm+d Browser

NHSBSA medicines dictionary lookup

SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).

Active and completed clinical studies from ClinicalTrials.gov

Show details

Searching UK clinical trials...

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.

Pharmacology and chemical data from DrugBank

go.drugbank.com

Key facts

Drug status

Approved

Major interactions

1 found

Half-life

3.5 hours

Mechanism

Terfenadine competes with histamine for binding at H1-receptor sites in the GI t…

Food interactions

2 warnings

Human targets

7 targets

Data: DrugBank · CC BY-NC 4.0

Pharmacokinetics at a glance

Absorption

70%

On the basis of a mass balance study using 14C labeled terfenadine the oral absorption of terfenadine was estimated to be at least 70%

Half-life

3.5 hours

3.5 hours

Protein binding

70%

Metabolism

Hepatic

Pharmacokinetic data: DrugBank · CC BY-NC 4.0

Status:

Approved

Withdrawn

Small molecule

About this compound

In the U.S., Terfenadine was superseded by fexofenadine in the 1990s due to the risk of cardiac arrhythmia caused by QT interval prolongation.

Properties:

solid

Avg. mass: 471.67 Da

DrugBank indication

For the treatment of allergic rhinitis, hay fever, and allergic skin disorders.

Also known as(80)

(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol

Terfenadin

Terfenadina

Terfénadine

Terfenadine

Terfenadinum

H1-R

H1R

Dosage forms(12)

Tablet (Oral) — 120 mg

Suspension (Oral)

Tablet (Oral) — 120 mg / tab

Tablet (Oral) — 60 mg / tab

Suspension (Oral) — 30 mg/5ml

Tablet (Oral)

Suspension (Oral) — 30 mg / 5 mL

Suspension (Oral) — 6 mg / mL

Molecular properties(19)

Drug interactions(1572)

Known interactions with other medications. Always consult a healthcare professional.

Reserpine

Moderate

DB00206

Reserpine may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Ursodeoxycholic acid

Moderate

DB01586

Ursodeoxycholic acid may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Cholic Acid

Moderate

DB02659

Cholic Acid may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Valinomycin

Moderate

DB14057

Valinomycin may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Olmesartan

Moderate

DB00275

Olmesartan may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Troglitazone

Moderate

DB00197

Troglitazone may decrease the excretion rate of Terfenadine which could result in a higher serum level.

Check this interaction

Eliglustat

Moderate

DB09039

The metabolism of Eliglustat can be decreased when combined with Terfenadine.

Check this interaction

Ibrutinib

Moderate

DB09053

The metabolism of Ibrutinib can be decreased when combined with Terfenadine.

Check this interaction

Erythromycin

Unknown severity

DB00199

The serum concentration of Terfenadine can be increased when it is combined with Erythromycin.

Check this interaction

Azithromycin

Unknown severity

DB00207

The serum concentration of Terfenadine can be increased when it is combined with Azithromycin.

Check this interaction

Roxithromycin

Unknown severity

DB00778

The serum concentration of Terfenadine can be increased when it is combined with Roxithromycin.

Check this interaction

Sirolimus

Unknown severity

DB00877

The serum concentration of Terfenadine can be increased when it is combined with Sirolimus.

Check this interaction

Dirithromycin

Unknown severity

DB00954

The serum concentration of Terfenadine can be increased when it is combined with Dirithromycin.

Check this interaction

Telithromycin

Unknown severity

DB00976

The serum concentration of Terfenadine can be increased when it is combined with Telithromycin.

Check this interaction

Candicidin

Unknown severity

DB01152

The serum concentration of Terfenadine can be increased when it is combined with Candicidin.

Check this interaction

Clarithromycin

Unknown severity

DB01211

The serum concentration of Terfenadine can be increased when it is combined with Clarithromycin.

Check this interaction

Josamycin

Unknown severity

DB01321

The serum concentration of Terfenadine can be increased when it is combined with Josamycin.

Check this interaction

Everolimus

Unknown severity

DB01590

The serum concentration of Terfenadine can be increased when it is combined with Everolimus.

Check this interaction

Epothilone D

Unknown severity

DB01873

The serum concentration of Terfenadine can be increased when it is combined with Epothilone D.

Check this interaction

Patupilone

Unknown severity

DB03010

The serum concentration of Terfenadine can be increased when it is combined with Patupilone.

Check this interaction

6-Deoxyerythronolide B

Unknown severity

DB04070

The serum concentration of Terfenadine can be increased when it is combined with 6-Deoxyerythronolide B.

Check this interaction

Ixabepilone

Unknown severity

DB04845

The serum concentration of Terfenadine can be increased when it is combined with Ixabepilone.

Check this interaction

KOS-1584

Unknown severity

DB05903

The serum concentration of Terfenadine can be increased when it is combined with KOS-1584.

Check this interaction

Spiramycin

Unknown severity

DB06145

The serum concentration of Terfenadine can be increased when it is combined with Spiramycin.

Check this interaction

Ridaforolimus

Unknown severity

DB06233

The serum concentration of Terfenadine can be increased when it is combined with Ridaforolimus.

Check this interaction

Temsirolimus

Unknown severity

DB06287

The serum concentration of Terfenadine can be increased when it is combined with Temsirolimus.

Check this interaction

AVE9633

Unknown severity

DB06318

The serum concentration of Terfenadine can be increased when it is combined with AVE9633.

Check this interaction

Coltuximab ravtansine

Unknown severity

DB06342

The serum concentration of Terfenadine can be increased when it is combined with Coltuximab ravtansine.

Check this interaction

Cethromycin

Unknown severity

DB06419

The serum concentration of Terfenadine can be increased when it is combined with Cethromycin.

Check this interaction

Mitemcinal

Unknown severity

DB06587

The serum concentration of Terfenadine can be increased when it is combined with Mitemcinal.

Check this interaction

Brefeldin A

Unknown severity

DB07348

The serum concentration of Terfenadine can be increased when it is combined with Brefeldin A.

Check this interaction

Solithromycin

Unknown severity

DB09308

The serum concentration of Terfenadine can be increased when it is combined with Solithromycin.

Check this interaction

Kitasamycin

Unknown severity

DB09309

The serum concentration of Terfenadine can be increased when it is combined with Kitasamycin.

Check this interaction

Carbomycin

Unknown severity

DB11383

The serum concentration of Terfenadine can be increased when it is combined with Carbomycin.

Check this interaction

Eprinomectin

Unknown severity

DB11405

The serum concentration of Terfenadine can be increased when it is combined with Eprinomectin.

Check this interaction

Oleandomycin

Unknown severity

DB11442

The serum concentration of Terfenadine can be increased when it is combined with Oleandomycin.

Check this interaction

Selamectin

Unknown severity

DB11459

The serum concentration of Terfenadine can be increased when it is combined with Selamectin.

Check this interaction

Tildipirosin

Unknown severity

DB11470

The serum concentration of Terfenadine can be increased when it is combined with Tildipirosin.

Check this interaction

Tilmicosin

Unknown severity

DB11471

The serum concentration of Terfenadine can be increased when it is combined with Tilmicosin.

Check this interaction

Tylosin

Unknown severity

DB11475

The serum concentration of Terfenadine can be increased when it is combined with Tylosin.

Check this interaction

Tylvalosin

Unknown severity

DB11554

The serum concentration of Terfenadine can be increased when it is combined with Tylvalosin.

Check this interaction

Bryostatin 1

Unknown severity

DB11752

The serum concentration of Terfenadine can be increased when it is combined with Bryostatin 1.

Check this interaction

Lorvotuzumab mertansine

Unknown severity

DB12089

The serum concentration of Terfenadine can be increased when it is combined with Lorvotuzumab mertansine.

Check this interaction

Epofolate

Unknown severity

DB12266

The serum concentration of Terfenadine can be increased when it is combined with Epofolate.

Check this interaction

Sagopilone

Unknown severity

DB12391

The serum concentration of Terfenadine can be increased when it is combined with Sagopilone.

Check this interaction

Mirvetuximab soravtansine

Unknown severity

DB12489

The serum concentration of Mirvetuximab Soravtansine can be increased when it is combined with Terfenadine.

Check this interaction

Troleandomycin

Unknown severity

DB13179

The serum concentration of Terfenadine can be increased when it is combined with Troleandomycin.

Check this interaction

Miocamycin

Unknown severity

DB13287

The serum concentration of Terfenadine can be increased when it is combined with Miocamycin.

Check this interaction

Flurithromycin

Unknown severity

DB13338

The serum concentration of Terfenadine can be increased when it is combined with Flurithromycin.

Check this interaction

Rokitamycin

Unknown severity

DB13409

The serum concentration of Terfenadine can be increased when it is combined with Rokitamycin.

Check this interaction

Showing 50 of 1572 interactions

Food & lifestyle interactions

Avoid Grapefruit

Exercise caution with grapefruit products. Grapefruit is a CYP3A4 inhibitor, and terfenadine is metabolized by CYP3A4. Co-administration may increase terfenadine concentrations and the risk of QT prolongation.

Advice

Exercise caution with St. John's Wort. This herb induces CYP3A4 and terfenadine is a substrate of CYP3A4.

Toxicity & overdose

Mild (e.g., headache, nausea, confusion), but adverse cardiac events including cardiac arrest, ventricular arrhythmias including torsades de pointes and QT prolongation have been reported. LD₅₀=mg/kg (orally in mice)

How it works

Mechanism of action

Terfenadine competes with histamine for binding at H1-receptor sites in the GI tract, uterus, large blood vessels, and bronchial muscle. This reversible binding of terfenadine to H1-receptors suppresses the formation of edema, flare, and pruritus resulting from histaminic activity. As the drug does not readily cross the blood-brain barrier, CNS depression is minimal.

Pharmacodynamics

Terfenadine, an H1-receptor antagonist antihistamine, is similar in structure to astemizole and haloperidol, a butyrophenone antipsychotic. The active metabolite of terfenadine is fexofenadine.

Pharmacokinetics

How the body processes this drug — absorption, distribution, metabolism, and elimination

Absorption

On the basis of a mass balance study using 14C labeled terfenadine the oral absorption of terfenadine was estimated to be at least 70%

Half-life

3.5 hours

Protein binding

70%

Metabolism

Hepatic

Drug targets(7)

Proteins and enzymes this drug interacts with in the body

Histamine H1 receptor

BE0000442

HRH1

antagonist

Specific functionhistamine receptor activity

Cellular location

Cell membrane

General function & pharmacology

G-protein-coupled receptor for histamine, a biogenic amine that functions as an immune modulator and a neurotransmitter .
PMID:33828102 PMID:8280179
Through the H1 receptor, histamine mediates the contraction of smooth muscles and increases capillary permeability due to contraction of terminal venules. Also mediates neurotransmission in the central nervous system and thereby regulates circadian rhythms, emotional and locomotor activities as well as cognitive functions (By similarity)

Muscarinic acetylcholine receptor M3

BE0000045

CHRM3

antagonist

Specific functionacetylcholine binding

Cellular location

Cell membrane

General function & pharmacology

The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover

Muscarinic acetylcholine receptor M1

BE0000092

CHRM1

binder

Specific functionG protein-coupled acetylcholine receptor activity

Cellular location

Cell membrane

General function & pharmacology

Muscarinic acetylcholine receptor M5

BE0000247

CHRM5

binder

Specific functionG protein-coupled acetylcholine receptor activity

Cellular location

Cell membrane

General function & pharmacology

Muscarinic acetylcholine receptor M4

BE0000405

CHRM4

binder

Specific functionG protein-coupled acetylcholine receptor activity

Cellular location

Cell membrane

General function & pharmacology

Metabolizing enzymes(6)

Enzymes involved in drug metabolism — important for understanding drug interactions

Enzyme activity key

substrate

inhibitor

inducer

CYP3A4Cytochrome P450 3A4

substrate

inhibitor

CYP3A7Cytochrome P450 3A7

substrate

CYP2D6Cytochrome P450 2D6

substrate

inhibitor

CYP3A5Cytochrome P450 3A5

substrate

CYP2C8Cytochrome P450 2C8

inhibitor

CYP2J2Cytochrome P450 2J2

inhibitor

Transporters(2)

Proteins that transport this drug across cell membranes

ATP-dependent translocase ABCB1

BE0001032

ABCB1

inhibitor

Specific functionABC-type xenobiotic transporter activity

Cellular location

Cell membrane

General function & pharmacology

Translocates drugs and phospholipids across the membrane .
PMID:2897240 PMID:35970996 PMID:8898203 PMID:9038218 PMID:35507548

Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins .
PMID:8898203
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells PMID:2897240 PMID:35970996 PMID:9038218

Bile salt export pump

BE0000703

ABCB11

substrate

Specific functionABC-type bile acid transporter activity

Cellular location

Apical cell membrane

General function & pharmacology

Catalyzes the transport of the major hydrophobic bile salts, such as taurine and glycine-conjugated cholic acid across the canalicular membrane of hepatocytes in an ATP-dependent manner, therefore participates in hepatic bile acid homeostasis and consequently to lipid homeostasis through regulation of biliary lipid secretion in a bile salts dependent manner .
PMID:15791618 PMID:16332456 PMID:18985798 PMID:19228692 PMID:20010382 PMID:20398791 PMID:22262466 PMID:24711118 PMID:29507376 PMID:32203132

Transports taurine-conjugated bile salts more rapidly than glycine-conjugated bile salts .
PMID:16332456
Also transports non-bile acid compounds, such as pravastatin and fexofenadine in an ATP-dependent manner and may be involved in their biliary excretion PMID:15901796 PMID:18245269

Carriers(2)

Proteins that carry this drug through the body

Alpha-1-acid glycoprotein 2

BE0004879

ORM2

binder

regulator

Cellular location

Secreted

General function & pharmacology

Functions as a transport protein in the blood stream. Binds various hydrophobic ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability.

Appears to function in modulating the activity of the immune system during the acute-phase reaction

Albumin

BE0000530

ALB

binder

regulator

Specific functionantioxidant activity

Cellular location

Secreted

General function & pharmacology

Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc .
PMID:19021548
Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity).

Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity).

Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli .
PMID:6234017
Does not prevent iron uptake by the bacterial siderophore aerobactin PMID:6234017

Biological pathways(1)

Terfenadine H1-Antihistamine Action

Involved compounds

Calcium,Terfenadine

ATC classification(1 code)

ATC R06AX12

Affected organisms(1)

Humans and other mammals

International brands(12)

Experimental properties(3)

External resources(2)

RxList Drugs.com

Commercial products(11)

Chemical identifiers

CAS, UNII, InChI Key and database cross-references

Show

Linked compound data from DrugBank Open Data (CC BY-NC 4.0)

Terfenadine

DB00342

CAS number

50679-08-8

UNII (FDA)

7BA5G9Y06Q

InChI Key (molecular fingerprint)

GUGOEEXESWIERI-UHFFFAOYSA-N

Additional database identifiers

Drugs Product Database (DPD)

1918

ChEBI

9453

PubChem Compound

5405

PubChem Substance

46507007

KEGG Compound

C07463

KEGG Drug

D00521

ChemSpider

5212

BindingDB

50017376

PharmGKB

PA451619

Therapeutic Targets Database

DAP000102

IUPHAR

2608

Guide to Pharmacology

2608

Wikipedia

Terfenadine

ChEMBL

CHEMBL17157

RxCUI

42330

HUGO Gene Nomenclature Committee (HGNC)

HGNC:5182

GenAtlas

HRH1

GeneCards

HRH1

GenBank Gene Database

Z34897

GenBank Protein Database

510296

IUPHAR

262

Guide to Pharmacology

262

UniProtKB

P35367

UniProt Accession

HRH1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1952

GenAtlas

CHRM3

GeneCards

CHRM3

GenBank Gene Database

X15266

GenBank Protein Database

32324

IUPHAR

Guide to Pharmacology

UniProtKB

P20309

UniProt Accession

ACM3_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1950

GenAtlas

CHRM1

GeneCards

CHRM1

GenBank Gene Database

X52068

GenBank Protein Database

34451

IUPHAR

Guide to Pharmacology

UniProtKB

P11229

UniProt Accession

ACM1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1954

GenAtlas

CHRM5

GeneCards

CHRM5

GenBank Gene Database

M80333

GenBank Protein Database

177988

IUPHAR

Guide to Pharmacology

UniProtKB

P08912

UniProt Accession

ACM5_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1953

GenAtlas

CHRM4

GeneCards

CHRM4

GenBank Gene Database

M16405

GenBank Protein Database

61970253

IUPHAR

Guide to Pharmacology

UniProtKB

P08173

UniProt Accession

ACM4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1951

GenAtlas

CHRM2

GeneCards

CHRM2

GenBank Gene Database

M16404

GenBank Protein Database

177990

IUPHAR

Guide to Pharmacology

UniProtKB

P08172

UniProt Accession

ACM2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:6251

GenAtlas

KCNH2

GeneCards

KCNH2

GenBank Gene Database

U04270

GenBank Protein Database

487738

IUPHAR

572

Guide to Pharmacology

572

UniProtKB

Q12809

UniProt Accession

KCNH2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2637

GenAtlas

CYP3A4

GeneCards

CYP3A4

GenBank Gene Database

M18907

Guide to Pharmacology

1337

UniProtKB

P08684

UniProt Accession

CP3A4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2640

GeneCards

CYP3A7

GenBank Gene Database

D00408

GenBank Protein Database

220149

UniProtKB

P24462

UniProt Accession

CP3A7_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2625

GenAtlas

CYP2D6

GeneCards

CYP2D6

GenBank Gene Database

M20403

GenBank Protein Database

181350

Guide to Pharmacology

1329

UniProtKB

P10635

UniProt Accession

CP2D6_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2638

GenAtlas

CYP3A5

GeneCards

CYP3A5

GenBank Gene Database

J04813

GenBank Protein Database

181346

Guide to Pharmacology

1338

UniProtKB

P20815

UniProt Accession

CP3A5_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2622

GenAtlas

CYP2C8

GeneCards

CYP2C8

GenBank Gene Database

M17397

Guide to Pharmacology

1325

UniProtKB

P10632

UniProt Accession

CP2C8_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2634

GeneCards

CYP2J2

GenBank Gene Database

U37143

GenBank Protein Database

18254513

Guide to Pharmacology

1332

UniProtKB

P51589

UniProt Accession

CP2J2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:8498

GenAtlas

ORM1

GeneCards

ORM1

GenBank Gene Database

X02544

GenBank Protein Database

757907

UniProtKB

P02763

UniProt Accession

A1AG1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:8499

GeneCards

ORM2

GenBank Gene Database

BC015964

GenBank Protein Database

16359000

UniProtKB

P19652

UniProt Accession

A1AG2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:399

GenAtlas

ALB

GeneCards

ALB

GenBank Gene Database

V00494

GenBank Protein Database

28590

UniProtKB

P02768

UniProt Accession

ALBU_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:40

GenAtlas

ABCB1

GeneCards

ABCB1

GenBank Gene Database

M14758

GenBank Protein Database

307180

Guide to Pharmacology

768

UniProtKB

P08183

UniProt Accession

MDR1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:42

GenAtlas

ABCB11

GeneCards

ABCB11

GenBank Gene Database

AF091582

GenBank Protein Database

3873243

Guide to Pharmacology

778

UniProtKB

O95342

UniProt Accession

ABCBB_HUMAN

DrugBank citations

If you use DrugBank data in your research, please cite the following publications:

Knox C., Wilson M., Klinger C.M., et al

DrugBank 6.

0: the DrugBank Knowledgebase for 2024

Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275

PMID: 37953279

Wishart D.S., Feunang Y.D., Guo A.C., et al

DrugBank 5.

0: a major update to the DrugBank database for 2018

Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082

PMID: 29126136

Show earlier publications

Law V., Knox C., Djoumbou Y., et al

DrugBank 4.

0: shedding new light on drug metabolism

Nucleic Acids Res. 2014 Jan 142(1):D1091-7

PMID: 24203711

Knox C., Law V., Jewison T., et al

DrugBank 3.

0: a comprehensive resource for 'omics' research on drugs

Nucleic Acids Res. 2011 Jan39(Database issue):D1035-41

PMID: 21059682

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Nucleic Acids Research

2008 Jan36(Database issue):D901-6

PMID: 18048412

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Nucleic Acids Research

2006 Jan 134(Database issue):D668-72

PMID: 16381955

Source: go.drugbank.comCC BY-NC 4.0

Updated about 1 month ago(4 Mar 2026)

Back to medicines

Terfenadine 60mg tablets

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

WHO defined daily dose (DDD)

British National Formulary

NICE clinical guidance(1)

Pharmacy stock checkers

Supply & product information

NHS UK identifiers

International identifiers

Browse tools

Key facts

Pharmacokinetics at a glance

Absorption

Half-life

Protein binding

Metabolism

Clinical essentials

Pharmacology

Deep science
18

Chemical identifiers

Terfenadine

Additional database identifiers

DrugBank citations

Terfenadine 60mg tablets

Safety & regulatory

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

Brand versions and licensed products

NHS reimbursement price

WHO defined daily dose (DDD)

Medicines like this

Prescribing statistics

Guidance (NICE / BNF)

British National Formulary

NICE clinical guidance(1)

Availability, stocks & shortages

Pharmacy stock checkers

Supply & product information

Professional identifiers

NHS UK identifiers

International identifiers

Browse tools

Clinical trials

DrugBank data

Key facts

Pharmacokinetics at a glance

Absorption

Half-life

Protein binding

Metabolism

Clinical essentials

Pharmacology

Deep science18

Chemical identifiers

Terfenadine

Additional database identifiers

DrugBank citations

Deep science
18